- Nachrichtendetail
-
05.06.2024 08:19:50 - dpa-AFX: *GILEAD SCIENCES' SELADELPAR SHOWS LONG-TERM EFFICACY, SAFETY IN PRIMARY BILIARY CHOLANGITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Gilead Sciences | 885823 | NASDAQ | 69,300 | 26.06.24 22:00:41 | -0,310 | -0,45% | 69,150 | 69,310 | 70,640 | 69,610 |
